Streetbeat News

Stock Prices

MHUA

Meihua International Medical Technologies shares are trading higher after the company announced its NT-2000 surgical path analysis system successfully supported the world's second 5G remote robot-assisted lobectomy.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:12 pm

META

Meta Platforms Inc (NASDAQ:META) is expected to report $4.72 in earnings per share and $38.3 billion in revenues for Q2. The stock is currently experiencing slight selling pressure, trading below its 5, 20, and 50-day exponential moving averages, indicating a bearish trend. However, the 200-day SMA and RSI suggest potential for a reversal. Analysts maintain a Buy rating with a 20% upside potential.

Portfolio Pulse from Surbhi Jain

July 31, 2024 | 1:11 pm

TSLA

Tesla's Full Self-Driving (FSD) system is under scrutiny following a fatal motorcycle accident near Seattle involving a 2022 Tesla Model S. The driver admitted to using the Autopilot system and being distracted by his cellphone. The incident raises questions about the safety of Tesla's self-driving technology.

Portfolio Pulse from Benzinga Neuro

July 31, 2024 | 1:10 pm

PARA

PARAA

Apex Capital Trust has submitted a $43 billion all-cash offer to acquire Paramount Global, proposing to purchase 100% of National Amusements Inc.'s capital stock and assume $15.8 billion in debt. This offer is intended to facilitate a 'go-shop' provision against a deal with Skydance.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:09 pm

BSX

BX

DXCM

EW

JOBY

LOW

MRVL

SLB

Jim Cramer provided stock recommendations on CNBC's 'Mad Money Lightning Round,' highlighting several companies. He recommended buying Lowe’s Companies, Inc. (LOW) ahead of the Federal Reserve's rate cut cycle and expressed positive views on Blackstone Inc. (BX) and Marvell Technology, Inc. (MRVL). He suggested selling Joby Aviation, Inc. (JOBY) and swapping Edwards Lifesciences Corporation (EW) for Boston Scientific (BSX). Cramer also preferred Schlumberger NV (SLB) over Borr Drilling Limited (BORR) and Abbott (ABT) over DexCom, Inc. (DXCM).

Portfolio Pulse from Avi Kapoor

July 31, 2024 | 1:08 pm

FULC

Fulcum Therapeutics shares are trading higher after the company reported a year-over-year increase in Q2 EPS results.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:07 pm

AMZN

GAME

GameSquare's Q2 2024 report highlights a 10% increase in live-streaming viewership from Q2 2023, reaching 8.5 billion hours watched. Twitch's market share has declined from 70% in Q2 2023 to 60% in Q2 2024, indicating a shift in the live streaming market.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:05 pm

SYTA

Siyata Mobile Inc. (NASDAQ: SYTA) announced a 1-for-18 reverse stock split effective August 2, 2024. The stock will trade on a post-split basis under the same symbol, SYTA, with a new CUSIP number.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:04 pm

MO

Altria Group Inc (NYSE:MO) reported a 3% year-on-year decline in Q2 FY24 revenues to $5.28 billion, missing analyst estimates. The decline was driven by a 5.6% decrease in smokeable products revenue, partially offset by a 4.6% increase in oral tobacco products revenue. Adjusted EPS of $1.31 missed the consensus of $1.34. Despite setbacks, Altria's smoke-free products showed strong performance. The company narrowed its FY24 adjusted EPS guidance to $5.07 – $5.15.

Portfolio Pulse from Shivani Kumaresan

July 31, 2024 | 1:03 pm

GOVX

GeoVax plans a Phase 2 trial for its Gedeptin therapy in first-recurrence head and neck cancer with an immune checkpoint inhibitor. The review of the Phase 1b/2a trial shows acceptable safety and efficacy, with no new safety signals identified. Tumor stabilization and reduction support continued development.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 1:01 pm